Davis's Drug Guide
empagliflozin/linagliptin
General
**BEERS Drug**
Pronunciation:
em-pa-gli-floe-zin/lin-a-glip-tin
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Glyxambi
Ther. Class.
Pharm. Class.
sodium-glucose co-transporter 2 (SGLT2) inhibitors
dipeptidyl peptidase-4 (DDP-4) inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Empagliflozin/linagliptin." Davis's Drug Guide, 18th ed., F.A. Davis Company, 2023. www.drugguide.com/ddo/view/Davis-Drug-Guide/110361/all/empagliflozin_linagliptin.
Vallerand AHA, Sanoski CAC, Quiring CC. Empagliflozin/linagliptin. Davis's Drug Guide. F.A. Davis Company; 2023. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/110361/all/empagliflozin_linagliptin. Accessed December 2, 2023.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2023). Empagliflozin/linagliptin. In Davis's Drug Guide (18th ed.). F.A. Davis Company. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/110361/all/empagliflozin_linagliptin
Vallerand AHA, Sanoski CAC, Quiring CC. Empagliflozin/linagliptin [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2023. [cited 2023 December 02]. Available from: https://www.drugguide.com/ddo/view/Davis-Drug-Guide/110361/all/empagliflozin_linagliptin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - empagliflozin/linagliptin
ID - 110361
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://www.drugguide.com/ddo/view/Davis-Drug-Guide/110361/all/empagliflozin_linagliptin
PB - F.A. Davis Company
ET - 18
DB - Davis's Drug Guide
DP - Unbound Medicine
ER -